PharmacovigilanceOfficial

INFARMED joins #MedSafetyWeek 2026 for eleventh year, urging reporting of suspected adverse reactions

🇵🇹 INFARMED · Mon 02 Nov 2026

Portugal's medicines authority is taking part in the international campaign running 2–8 November 2026 under a slogan telling people not to ignore suspected adverse drug reactions.

INFARMED, Portugal's national authority for medicines and health products, has announced its participation in #MedSafetyWeek 2026. It describes this as the eleventh consecutive year in which it has joined the international initiative.

The campaign runs from 2 to 8 November 2026. Its slogan, in the authority's Portuguese wording, translates as: do not ignore suspected adverse reactions, report them.

The source text is brief and points readers to an attached press release for further information. That attachment was not available, so details of planned activities, materials or reporting channels in Portugal are not covered here.

As general context, #MedSafetyWeek is an annual social media campaign that encourages patients and healthcare professionals to report suspected adverse drug reactions. Spontaneous reports of this kind are a core input to pharmacovigilance systems.

What it means for your team

  • Pharmacovigilance teams in Portugal may see more spontaneous reports from patients and healthcare professionals in and shortly after the 2–8 November campaign week.
  • Marketing authorisation holders should check that their case intake and processing, including for reports received through national authorities, can handle a short-term rise in volume.
  • Companies with Portuguese operations may wish to align internal communications or healthcare professional outreach on reporting with the campaign period, in line with their own compliance rules.

Official source: INFARMED ↗

Article written by VigiEye from the official source (INFARMED). AI-assisted; check the source before acting.

More Pharmacovigilance All →